Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
P.F. Whitington, W.F. Balistreri.
Liver transplantation in pediatrics: Indications, contraindicatons and pretransplant management.
J Pediatr, 118 (1991), pp. 169-177
[2.]
M. Davenport, N. Kerkar, G. Mieli-Vergani, A.P. Mowat, E.R. Howard.
Biliary atresia: The King's College Hospital experience (1974-1995).
J Pediatr Surg, 32 (1997), pp. 479-485
[3.]
J. Cardona, D. Haossin, F. Gauthier, D. De Victor, J. Losay, M. Had-chouel, et al.
Liver transplantation in children with Alagille syn-drome: A study of twelve cases.
Transplantation, 60 (1995), pp. 339-342
[4.]
J.J. Fox, J.R. Chowdhury, S.S. Kaufman, et al.
Treatment of Crigler-najjar syndrome type 1 with hepatocyte transplantation.
New England J Med, 338 (1998), pp. 1422-1426
[5.]
M. Rela, P. Muiesan, P. Andreani, P. Gibbs, G. Mieli Vergani, A.P. Mowat, et al.
Auxiliary liver transplantation for metabolic diseases.
Transplant Proc, 29 (1997), pp. 444-445
[6.]
J. Noble, G. Jamieson, L. Barnes.
Liver transplantation for cirrho-sis in cystic fibrosis.
J Pediatr 1996;314., 314 (1996),
[7.]
H. Bismuth, D. Houssin.
Reduced-size orthotopic liver graft in hepatic transplantation in children.
Surgery, 95 (1984), pp. 367
[8.]
C.E. Broelsch, P.F. Whitington, J.C. Emond, T.G. Heffron, J.R. Thistleth-waite, L. Stevens, et al.
Liver transplantation in children from living related donors.
Ann Surg, 214 (1991), pp. 428
[9.]
X. Rogiers, M. Malago, N. Habbit, W.T. Knoefel, W. Pothmann, M. Burdelski, et al.
In situ splitting of the liver in the hearth-bea-ting cadaveric organ donor for transplantation in two reci-pients.
Transplantation, 59 (1995), pp. 1081
[10.]
J.B. Otte, J. De Ville de Goyet, E. Sokal, D. Alberti, D. Moulin, B. De Hemptinne, et al.
Size reduction of the donor liver is a safe way to alleviate the shortage of size-matched organs in pediatric liver transplantation.
Ann Surg, 211 (1990), pp. 146
[11.]
R.J. Ploeg, A.M. Dálessandro, S.J. Knechtle.
Risk factors for primary disfunction after liver transplantation. A multivariate analysis.
Transplantation, 55 (1993), pp. 807-813
[12.]
M. Bruguera.
Generalidades. Rechazo. Hepatitis por CMV. Com-plicaciones biliares.
Trasplante Hepático de Berenguer y Parrilla, pp. 295-301
[13.]
M.A. Delgado, R.E. Frauca.
Tratamiento en el postoperatorio inmediato y complicaciones del trasplante hepático. En Ruza F.
Tratado de Cuidados Intensivos Pediátricos, pp. 2115-2122
[14.]
S. McDiarmid, S. Jordan, G. Lee, M. Toyoda, J.A. Gross, J.H. Vargas, et al.
Prevention and preemptive therapy of posttransplant lymphoproliferative disease in pediatric liver transplant reci-pients.
Transplantation, 66 (1998), pp. 1604-1611
[15.]
B.S. Younes, S.V. McDiarmid, M.G. Martin, et al.
The effect of inmunosuppression on posttransplant lymphoproliferative disease in pediatric liver transplant patients.
Transplantatión, 70 (2000), pp. 94-99
[16.]
S.V. McDiarmid, R.V. Bussutil, N.L. Ascher, J. Burdick, A. D'Alessandro, C. Esquivel.
FK-506 (tacrolimus) compared with cyclosporine for primary inmunossupresion after pediatric liver transplanta-tion: Results from the U.S. Multicenter Trial.
Transplantation, 59 (1995), pp. 530
[17.]
D.A. Kelly.
The use of anti-interleukin-2 receptor antibodies in pediatric liver transplantation.
Pediatr Transplantation, 5 (2001), pp. 386-389
[18.]
M. Green, J. Reyes, S. Webber, D. Rowe.
The role of antiviral and inmunoglobulin therapy in the prevention of Epstein-Barr virus infection and post-transplant lymphoproliferative disease follo-wing solid organ transplantation.
Transpl Infect Dis, 3 (2001), pp. 97-103
[19.]
R.H. Wiesner, J. Ludwig, R.K. Krom, J.E. Hay, B. Hoek.
Hepatic allo-graft rejection: New developments in terminology, diagnosis, prevention and treatment.
Mayo Clin Proc, 68 (1993), pp. 69-79
Copyright © 2004. Asociación Española de Pediatría
